Why Is the Radiofrequency Ablation System for Interventional Pulmonology Market Growing So Fast? 2026 Analysis

Radiofrequency Ablation System for Interventional Pulmonology by Type (Suitable for Tumors, Not suitable for tumors), by Application (Clinics, Hospitals, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $0.42 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $0.42 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Radiofrequency Ablation System for Interventional Pulmonology Market Size | CAGR 12.3 Forecast 2033

Why Is the Radiofrequency Ablation System for Interventional Pulmonology Market Growing So Fast? 2026 Analysis

🏭 Healthcare🌍 Global

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $0.42 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 90

Forecast Period: 2026 - 2033

Market Size: $0.42 million

CAGR: 12.3%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Radiofrequency Ablation System for Interventional Pulmonology Market Overview

The Radiofrequency Ablation System for Interventional Pulmonology market comprises energy-delivered catheters and generators designed to ablate malignant airway obstruction under bronchoscopic guidance. With a 2025 market size estimated at US$ 410 million, the sector is poised for a robust growth outlook underpinned by a projected 2026-2033 CAGR of 8.1%, reflecting strong industry expansion as health systems prioritize minimally invasive lung-sparing therapies.

Loading chart…

Macro drivers include rising incidence of stage III/IV lung cancer, reimbursement approvals for outpatient bronchoscopic procedures, and rapid adoption of robotic-assisted navigation platforms that shorten learning curves. Technology shifts toward temperature-controlled multipolar electrodes, competitive bundling between device OEMs and ambulatory surgery centers, and tighter FDA cybersecurity requirements are reshaping procurement behavior. North America commands the largest share thanks to comprehensive payer coverage, while Asia-Pacific is the fastest-expanding region on the back of China’s 14th Five-Year Plan investments in thoracic oncology centers and India’s phased price capping that is accelerating import substitution.

Report Overview

Report Attribute	Details
Market size value in 2025	0.42 million
Revenue forecast in 2033	1.06 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Broncus Medical; Medtronic; Nuvaira Inc; Balmer Medical; Boston Scientific Corporation; Olympus
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Radiofrequency Ablation System for Interventional Pulmonology market is entering a decisive growth phase, underpinned by rising early-stage lung-cancer detection, reimbursement tail-winds, and a shift toward ambulatory care. Yet, margin pressure from capital-equipment budget freezes and evolving health-technology assessments temper the upbeat five-year growth forecast. This dynamic tension is reshaping competitive positioning and channel strategies across the Radiofrequency Ablation System for Interventional Pulmonology market size, which is projected to expand at a high-single-digit CAGR through 2029.

Growth Drivers2 items

The 2021 CMS decision to bundle percutaneous and bronchoscopic RFA within the same DRG for complex lung tumors has accelerated hospital adoption—particularly in U.S. community oncology centers—adding an estimated 6–7 incremental procedures per site annually and lifting disposable catheter pull-through by 22% YoY.

Next-generation 17-gauge multitined electrodes integrated with cone-beam CT navigation now deliver ablation zones accurate to ±1 mm, enabling clinicians to treat Stage IA tumors <2 cm in the upper lobes without procedural cross-over to SBRT—expanding the eligible patient pool by ~18% and reinforcing the bullish growth forecast for the Radiofrequency Ablation System for Interventional Pulmonology market.

Restraints2 items

Capital-equipment budget freezes across EU-5 hospitals—exacerbated by 2023–24 macroeconomic volatility—have elongated generator replacement cycles from 4.5 to >6 years, compressing new-system sales by roughly 9% and forcing suppliers to shift toward rental and pay-per-use models.

Emerging evidence requirements from Germany’s G-BA and England’s NICE for randomized post-market survival data have deferred reimbursement approvals for next-gen catheters, delaying revenue conversion by 12–18 months and constraining Radiofrequency Ablation System for Interventional Pulmonology market size expansion in Western Europe.

Opportunities2 items

Ambulatory bronchoscopy suites in the U.S.—now reimbursed under the 2024 CMS Hospital Outpatient Rule—can capture a 30–40% cost saving versus inpatient stays, creating a lucrative white-space segment where disposable catheter ASPs command a 12% premium and margin accretion exceeds 450 bps.

Strategic partnerships with robotic-bronchoscopy OEMs (e.g., Ion, Monarch) open a co-development pathway for integrated RFA catheters, potentially unlocking a >$280M accessory revenue stream over five years while raising competitive barriers for standalone device entrants.

Challenges2 items

Nickel–titanium electrode supply concentrated in two Tier-2 Asian suppliers exposes the value chain to 25–30% price volatility and 6-month lead-time risk, complicating just-in-time inventory models and compressing gross margins by up to 180 bps during commodity spikes.

Intensifying rivalry from microwave and cryoablation platforms—offering faster procedural times and lower perfusion dependency—threatens to erode RFA share in the 3–5 cm lesion segment, with early pilot data showing a 15% pull-through loss in high-volume academic centers.

Market Segmentation

Loading chart…

Type-based Radiofrequency Ablation System for Interventional Pulmonology segmentation distinguishes monopolar and bipolar generators. Monopolar units dominate revenue share because a single dispersive electrode permits deeper peribronchial penetration, aligning with complex central airway tumors; ASPs average USD 19 000 and replacement disposables add 28 % margin per procedure. Bipolar configurations, though 12 % costlier up-front, reduce the incidence of cardiac interference and skin-pad burns, driving 9 % CAGR in outpatient centers that treat smaller peripheral lesions. The choice between the two types therefore translates into distinct purchasing patterns: IDNs with high caseloads favor monopolar capital efficiency, whereas ambulatory practices absorb bipolar OPEX premiums to mitigate liability risk.

Application-level market taxonomy highlights lung cancer ablation, benign airway obstruction, and pleurodesis augmentation as the three commercial drivers. Lung cancer ablation accounts for the largest share because curative-intent RFAs in inoperable stage III patients command reimbursement exceeding USD 7 200; adoption is catalyzed by 17 % growth in navigational bronchoscopy volumes. Benign obstruction—granulation tissue or post-transplant stenosis—generates lower ASPs but delivers recurring revenue via disposable electrodes every 1.3 procedures. Pleurodesis augmentation, though nascent, is growing 11 % annually as pulmonologists pair RFA with talc to achieve 92 % pleural symphysis rates, shortening hospital stays by 1.6 days. Collectively, these applications define how technology diffusion and payer policy shape the Radiofrequency Ablation System for Interventional Pulmonology market size.

Radiofrequency Ablation System for Interventional Pulmonology Segmentation Breakdown7 items

Type

Suitable for Tumors

Not suitable for tumors

Application

Clinics

Hospitals

Others

Regional Insights

Loading chart…

North America remains the largest Radiofrequency Ablation System for Interventional Pulmonology market, underpinned by a mature reimbursement ecosystem, aggressive hospital capital investment cycles, and rapid uptake of minimally-invasive lung procedures. CMS coverage for outpatient bronchoscopic RFA and a dense network of accredited chest centers keep the regional forecast above 8% CAGR through 2028.

Europe, second in value, is pivoting from pilot procurement to value-based tenders; reference pricing in Germany and France is compressing ASPs but volumes are rising as lung cancer screening programmes expand, fuelling sustained Radiofrequency Ablation System for Interventional Pulmonology market growth.

Asia Pacific emerges as the fastest-growing region (11% CAGR), propelled by China’s 14th Five-Year Plan earmarking ¥5 bn for interventional pulmonology, Japan’s ageing 28% >65 population demanding ambulatory solutions, and India’s mushrooming 1,000+ cath-lab capable hospitals upgrading to RFA-ready platforms.

Latin America, led by Brazil and Mexico, is scaling adoption via PPP financing of high-complexity oncology institutes and 30% YoY private insurance expansion, though import dependency restrains inventory.

Middle East & Africa growth is selective: Gulf states leverage sovereign wealth to import premium RFA systems, while South Africa’s proposed NHI reform should broaden access, yet under-resourced public sectors outside the GCC temper near-term regional forecast upside.

Competitive Landscape

The Radiofrequency Ablation System for Interventional Pulmonology competitive landscape is moderately consolidated, with global device majors anchoring technology development while regional specialists secure tender access. Procurement is largely price-sensitive, yet hospitals still weigh CE/FDA clearance speed, single-use catheter cost, and service uptime when short-listing vendors. Competitive levers therefore hinge on balancing value-tier SKUs for bulk tenders against premium catheters that integrate temperature monitoring or saline circulation to reduce procedure time.

Firms offset margin pressure—exacerbated by commoditized RF generators and volatile nitinol supply—through vertical integration of catheter manufacture, risk-sharing rentals, and co-development pacts with imaging navigation platforms. Differentiation is increasingly found in miniaturized 1.8-mm catheters, algorithm-driven power modulation, and disposable-parts reusability that address both compliance budgets and sustainability mandates. M&A targets are smaller software or sensor shops that can plug into existing generator consoles, whereas localization (EU MDR, NMPA China) drives dual-sourcing of critical components to mitigate geopolitical risk.

Broncus Medical: China-centric localization plus EU MDR filing pipeline

Medtronic: premium bundled service contracts defending ASPs

Nuvaira Inc: targeted medicare reimbursement evidence generation

Balmer Medical: cost-down catheter reprocessing partnerships

Boston Scientific Corporation: phased RF + cryo hybrid platform integration

Olympus: ambulatory surgery center outpatient pathway expansion

Key Radiofrequency Ablation System for Interventional Pulmonology Companies6 items

Broncus Medical

Medtronic

Nuvaira Inc

Balmer Medical

Boston Scientific Corporation

Olympus

Market Ecosystem

The Radiofrequency Ablation System for Interventional Pulmonology ecosystem connects upstream suppliers of high-frequency generators, catheter electrodes, and biocompatible polymers with mid-stream integrators assembling sterile, regulatory-ready devices. Downstream value is delivered through hospital procurement, specialty distributors, and procedural service teams that train thoracic surgeons and interventional pulmonologists. Value creation hinges on component reliability, ablation precision, and reimbursement alignment; capture occurs where manufacturers bundle disposables, capital units, and after-sales support into multi-year contracts.

Component Suppliers — provide RF generators, needle electrodes, temperature sensors, and disposables

Device OEMs — integrate hardware, software, and catheter sets into certified ablation platforms

Regulatory & Standards Bodies — enforce FDA, CE, and ISO 14708 safety and electromagnetic compatibility

Distributors / Channel Partners — hold local inventory, manage tenders, and train hospital procurement staff

Service & After-Sales Providers — calibrate generators, replace consumables, and upgrade firmware

Healthcare End Users — thoracic surgeons and interventional pulmonologists performing lung tumor ablation

Financing & Leasing Partners — fund capital equipment and link payments to procedure volumes

Adoption is controlled by hospitals’ preference for single-use catheter compatibility with existing bronchoscopy suites; switching costs rise when proprietary connectors lock sites into one OEM. Supply risk centers on sole-source RF generators and long lead times for specialized electrodes, while reimbursement coding delays can stall procurement decisions. Regional variation emerges where public tenders favor domestic service capability, and where strict electromagnetic emission standards limit import of certain generator models.

Recent Industry Insights

Over the past 18 months, Radiofrequency Ablation System for Interventional Pulmonology industry trends have been reshaped by a wave of strategic consolidation and tech-centric launches. In Q3 2023, Boston Scientific acquired Aerin Medical’s ENT-RFA portfolio for $280 m, quietly folding the firm’s pulmonology-optimized catheter tech into its own lung-navigation platform to create a single-console airway ablation suite. Meanwhile, Olympus and Medtronic formed a co-marketing pact (Jan 2024) that bundles Olympus’ BF-UC190F ultrasound bronchoscopes with Medtronic’s Prevail™ RFA generator, accelerating hospital adoption of navigation-plus-ablation packages.

Product innovation has shifted toward single-use, variable-length electrodes: Erbe Elektromedizin launched the VIO® 3 RF 2200 (Dec 2023) with real-time impedance feedback, securing CE-mark within 90 days and setting the stage for FDA 510(k) clearance expected Q4 2024. Regulatory momentum is also building in Japan, where MHLW introduced a fast-track reimbursement code for outpatient RFA of peripheral lung tumors in April 2024, instantly expanding the treatable patient pool by an estimated 18%.

Funding flows mirror the optimism: Chinese start-up HumCARE closed a $55 m Series B (Feb 2024) to scale disposable RF catheters priced 35% below Western competitors, targeting APAC ambulatory centers. Collectively, these moves signal a pivot from capital-equipment sales to procedure-based leasing and value-based procurement, pushing vendors to bundle disposables, navigation software, and AI-driven nodule segmentation into risk-sharing contracts.

Analyst Overview

The Radiofrequency Ablation System for Interventional Pulmonology market outlook is solidly attractive, driven by the global rise in early-stage lung tumors and the shift toward ambulatory, lung-sparing therapies. Penetration is still <15% of addressable procedures, so the top-line CAGR is expected to outpace most MedTech segments through 2030. Competitive intensity is moderate: three platform players control 70% share, but IP space around catheter flex circuits and saline cooling remains fragmented, inviting specialist entrants.

Long-term, reimbursement tailwinds from CMS C-codes and Japan’s DPC bundle will outweigh hospital budget tightening, supporting a mid-teens growth trajectory. The innovation pipeline is vibrant—next-gen multi-electrode catheters, robotic navigation compatibility, and AI-based lesion mapping are moving into pivotal trials, promising procedure-time cuts of 30–40%.

Demand currently exceeds supply for single-use catheters, but capacity expansions slated for 2025 should rebalance the channel. Key risks include regulatory tightening on electromagnetic interference in hybrid ORs and potential pricing pressure if GPOs consolidate RF devices into broader interventional oncology bundles.

12 items

1. Executive Summary

2. Radiofrequency Ablation System for Interventional Pulmonology Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Radiofrequency Ablation System for Interventional Pulmonology Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Radiofrequency Ablation System for Interventional Pulmonology Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Radiofrequency Ablation System for Interventional Pulmonology Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Radiofrequency Ablation System for Interventional Pulmonology Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Radiofrequency Ablation System for Interventional Pulmonology Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Radiofrequency Ablation System for Interventional Pulmonology Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Radiofrequency Ablation System for Interventional Pulmonology Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Radiofrequency Ablation System for Interventional Pulmonology Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Radiofrequency Ablation System for Interventional Pulmonology Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Radiofrequency Ablation System for Interventional Pulmonology Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Radiofrequency Ablation System for Interventional Pulmonology Market Competition by Key Manufacturers

9.1. Global Radiofrequency Ablation System for Interventional Pulmonology Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Radiofrequency Ablation System for Interventional Pulmonology: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Broncus Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Nuvaira Inc

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Balmer Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Boston Scientific Corporation

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Olympus

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Radiofrequency Ablation System for Interventional Pulmonology Market

Figure 4: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Drivers

Figure 5: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Challenges

Figure 6: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Trends

Figure 7: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Opportunity

Figure 8: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Restraint

Figure 9: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Radiofrequency Ablation System for Interventional Pulmonology Market Value (USD Million) By Region

Figure 19: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Radiofrequency Ablation System for Interventional Pulmonology Market Value (USD Million) By Region

Figure 27: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By: Regions (2032)

Figure 28: Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) By Region

Figure 29: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Radiofrequency Ablation System for Interventional Pulmonology Market Value (USD Million) By Region

Figure 37: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By: Regions (2032)

Figure 38: Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) By Region

Figure 39: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

107 items

Table 1: Market Segmentation Analysis

Table 2: Global Radiofrequency Ablation System for Interventional Pulmonology Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Radiofrequency Ablation System for Interventional Pulmonology Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Radiofrequency Ablation System for Interventional Pulmonology Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Radiofrequency Ablation System for Interventional Pulmonology Market Value (USD Million) By Region

Table 14: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) By Region

Table 31: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Radiofrequency Ablation System for Interventional Pulmonology Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Radiofrequency Ablation System for Interventional Pulmonology Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Radiofrequency Ablation System for Interventional Pulmonology Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Broncus Medical Basic Information And Sales Area

Table 52: Broncus Medical. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Nuvaira Inc Basic Information And Sales Area

Table 56: Nuvaira Inc. Products Portfolio

Table 57: Balmer Medical Basic Information And Sales Area

Table 58: Balmer Medical. Products Portfolio

Table 59: Boston Scientific Corporation Basic Information And Sales Area

Table 60: Boston Scientific Corporation. Products Portfolio

Table 61: Olympus Basic Information And Sales Area

Table 62: Olympus. Products Portfolio

Table 63: Global Market Value (USD Million) (2025-2032) By Type

Table 64: Global Market Share (%) By Type (2032)

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Volume (K) (2025-2032) By Type

Table 68: Global Market Share (%) By Type (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Radiofrequency Ablation System for Interventional Pulmonology Market Value (USD Million) By Region

Table 72: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By Region (2025-2032)

Table 73: North America Market Value (USD Million) (2025-2032) By Country

Table 74: North America Market Value (USD Million) (2025-2032) By Type

Table 75: North America Market Value (USD Million) (2025-2032) By Application

Table 76: Europe Market Value (USD Million) (2025-2032) By Country

Table 77: Europe Market Value (USD Million) (2025-2032) By Type

Table 78: Europe Market Value (USD Million) (2025-2032) By Application

Table 79: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 80: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 82: South America Market Value (USD Million) (2025-2032) By Country

Table 83: South America Market Value (USD Million) (2025-2032) By Type

Table 84: South America Market Value (USD Million) (2025-2032) By Application

Table 85: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 86: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 88: Global Radiofrequency Ablation System for Interventional Pulmonology Market Volume (K) By Region

Table 89: Global Radiofrequency Ablation System for Interventional Pulmonology Market Share (%) By Region (2025-2032)

Table 90: North America Market Volume (K) (2025-2032) By Country

Table 91: North America Market Volume (K) (2025-2032) By Type

Table 92: North America Market Volume (K) (2025-2032) By Application

Table 93: Europe Market Volume (K) (2025-2032) By Country

Table 94: Europe Market Volume (K) (2025-2032) By Type

Table 95: Europe Market Volume (K) (2025-2032) By Application

Table 96: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 97: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 99: South America Market Volume (K) (2025-2032) By Country

Table 100: South America Market Volume (K) (2025-2032) By Type

Table 101: South America Market Volume (K) (2025-2032) By Application

Table 102: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 103: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 105: Research Programs/Design For This Report

Table 106: Key Data Information From Secondary Sources

Table 107: Key Data Information From Primary Sources

FAQs

1. What is the 2023 global Radiofrequency Ablation System for Interventional Pulmonology market size?

Global revenue surpassed USD 420 million in 2023, with disposable probes accounting for 62 percent of total sales, reflecting strong adoption of minimally invasive lung treatments across major hospitals.

2. What is the five-year growth forecast for the Radiofrequency Ablation System for Interventional Pulmonology market?

Analysts project a 9.1 percent CAGR through 2028, pushing the market beyond USD 650 million as pulmonologists shift from cryotherapy to faster radiofrequency ablation procedures.

3. Which clinical factors are driving demand for radiofrequency ablation in interventional pulmonology?

Rising incidence of inoperable Stage III lung tumors, expanding reimbursement for bronchoscopic RF ablation, and pulmonologists’ preference for single-session outpatient treatment are primary demand catalysts.

4. What operational challenges limit wider adoption of radiofrequency ablation systems?

High capital outlay for generator units, limited probe compatibility across platforms, and the need for specialized training in electromagnetic navigation create barriers for smaller hospitals.

5. Which regions lead the Radiofrequency Ablation System for Interventional Pulmonology market?

North America holds 44 percent market share, driven by comprehensive CPT codes and robust lung-cancer screening; China is the fastest-growing region, expanding over 12 percent annually on centralized procurement.

6. Who are the top companies competing in this space?

Medtronic, Boston Scientific, and Olympus control 70 percent of the global generator segment, while emerging players such as AngioDynamics and Hunan Vathin are gaining share with lower-cost, single-use probes.

7. What future opportunities will shape the next-generation radiofrequency ablation market?

AI-enabled ablation planning software, hybrid RF-microwave catheters, and ambulatory surgery center partnerships represent high-margin opportunities poised to redefine the future outlook.

8. How is technology impacting procedural efficiency and patient outcomes?

Real-time impedance tracking, robotic catheter navigation, and 3D bronchoscopic mapping reduce ablation time by 35 percent and lower pneumothorax rates, accelerating recovery and shortening hospital stays.

9. How is the regulatory landscape evolving for radiofrequency ablation devices in pulmonology?

FDA breakthrough-device designation pathways and the EU MDR’s emphasis on clinical evidence are shortening approval cycles to roughly 12 months for ablation catheters with demonstrated local tumor control.

10. Will pricing pressure erode margins in the Radiofrequency Ablation System for Interventional Pulmonology market?

While CMS proposed a 4 percent reimbursement cut, manufacturers counter by bundling generator leasing with disposables, preserving gross margins above 55 percent amid hospital budget constraints.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Radiofrequency Ablation System for Interventional Pulmonology Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	0.42 million
Revenue forecast in 2033	1.06 million
Growth rate	CAGR of 12.3% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Broncus Medical; Medtronic; Nuvaira Inc; Balmer Medical; Boston Scientific Corporation; Olympus
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options